Recent Development of LDL-Based Nanoparticles for Cancer Therapy

Low-density lipoprotein (LDL), a natural lipoprotein transporting cholesterol in the circulatory system, has been a possible drug carrier for targeted delivery. LDL can bind to the LDL receptor (LDLR) with its outside apolipoprotein B-100 and then enter the cell via LDLR-mediated endocytosis. This t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Binghong, Yang, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863478/
https://www.ncbi.nlm.nih.gov/pubmed/36678515
http://dx.doi.org/10.3390/ph16010018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863478/
https://www.ncbi.nlm.nih.gov/pubmed/36678515
http://dx.doi.org/10.3390/ph16010018

Ejemplares similares